Effects of Sensor-Augmented Pump Therapy on Glycemic Variability in Well-Controlled Type 1 Diabetes in the STAR 3 Study

BACKGROUND: Compared with multiple daily injections (MDI), sensor-augmented pump (SAP) insulin therapy may reduce glycemic variability and oxidative stress in type 1 diabetes in a glycosylated hemoglobin (A1C)-independent manner. SUBJECTS AND METHODS: The STAR 3 study compared SAP with MDI therapy f...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Diabetes Technol Ther
Egile Nagusiak: Buse, John B., Kudva, Yogish C., Battelino, Tadej, Davis, Stephen N., Shin, John, Welsh, John B.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Mary Ann Liebert, Inc. 2012
Gaiak:
Original Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4696421/
https://ncbi.nlm.nih.gov/pubmed/22524549
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/dia.2011.0294
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak